Results 261 to 270 of about 58,087 (312)

The Safety and Efficacy of Peptide Receptor Radionuclide Therapy for Gastro-Entero-Pancreatic Neuroendocrine Tumors: A Single Center Experience. [PDF]

Curr Oncol
Piscopo L, Zampella E, Volpe F, Gaudieri V, Nappi C, Di Donna E, Clemente S, Varallo A, Scaglione M, Cuocolo A, Klain M.   +10 more
europepmc   +1 more source

Dosimetric evaluation of radionuclides for VCAM-1-targeted radionuclide therapy of early brain metastases

, 2017
Nadia Falzone, Nicole Ackerman, Liset de la Fuente Rosales, Mario A. Bernal, Xiaoxuan Liu, Sarah G.J.A. Peeters, Manuel Sarmiento Soto, Aurélien Corroyer‐Dulmont, Myriam Bernaudin, Elisa Grimoin, Omar Touzani, Nicola R. Sibson, Katherine A. Vallis   +12 more
openalex   +1 more source

Safety and Efficacy of Peptide Receptor Radionuclide Therapy (PRRT) Following Bland Embolization for Metastatic Neuroendocrine Tumors. [PDF]

Cancers (Basel)
Alayli A, Ngo H, Sikaria D, Ahmed A, Salloum E, Strosberg JR, Al-Toubah TE, Kis B, Haider M, El-Haddad G.   +9 more
europepmc   +1 more source

Radionuclide I-131 Labeled Albumin-Paclitaxel Nanoparticles for Synergistic Combined Chemo-radioisotope Therapy of Cancer

, 2017
Longlong Tian, Qian Chen, Xuan Yi, Guanglin Wang, Jie Chen, Ping Ning, Kai Yang, Zhuang Liu   +7 more
openalex   +1 more source

Investigating the Radiobiological Response to Peptide Receptor Radionuclide Therapy Using Patient-Derived Meningioma Spheroids. [PDF]

Cancers (Basel)
Reuvers TGA, Grandia V, Brandt RMC, Arab M, Maas SLN, Bos EM, Nonnekens J.   +6 more
europepmc   +1 more source

Assessment of psychological status by a comprehensive approach in thyroid cancer patients undergoing radionuclide therapy: A feasibility study. [PDF]

Sci Prog
Giordano A, Bochicchio I, Gallicchio R, Deiana G, Storto R, Nardelli A, Di Cosola M, Lettini A, Storto G.   +8 more
europepmc   +1 more source

Role of neoadjuvant peptide receptor radionuclide therapy in unresectable and metastatic gastro-entero-pancreatic neuroendocrine neoplasms: A scoping review. [PDF]

J Neuroendocrinol
Kashyap R, Raja S, Adusumilli A, Gopireddy MMR, Loveday BPT, Alipour R, Kong G.   +6 more
europepmc   +1 more source

Safety and efficacy of peptide receptor radionuclide therapy in neuroendocrine tumors: A single center experience. [PDF]

PLoS One
Sukrithan V, Armbruster H, Rogers S, Vogt SM, Grenade C, Verschraegen C, Zhou Y, Goyal A, Natwa M, Hussein A, Barr H, Konate D, Batdorf R, Brown A, Williams B, Zhao S, Wei L, Xu M, Shah MH, Konda B.   +19 more
europepmc   +1 more source

Targeted radionuclide therapy against GARP expressing T regulatory cells after tumour priming with external beam radiotherapy in a murine syngeneic model. [PDF]

Heliyon
Bellaye PS, Dias AM, Vrigneaud JM, Bouchard A, Moreau M, Petitot C, Bernhard C, Claron M, Froidurot L, Morgand V, Guillemin M, Monterrat M, Mirjolet C, Garrido C, Kohli E, Collin B.   +15 more
europepmc   +1 more source

Grade 3 Pancreatic Neuroendocrine Tumor Refractory to Chemotherapy Successfully Treated with Peptide Receptor Radionuclide Therapy Leading to Conversion Surgery. [PDF]

Intern Med
Sakaki K, Chiba M, Iijima K, Goto T, Arita J, Tsuda H.   +5 more
europepmc   +1 more source